GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM31097
Query DataSets for GSM31097
Status
Public on Oct 28, 2004
Title
CBCD34_setE_2hr
Sample type
RNA
Source name
umbilical cord blood CD34+ cells, 2 hrs TGF-beta treatment
Organism
Homo sapiens
Extracted molecule
total RNA
Description
Total RNA
RNeasy extraction
Two rounds amplification (RT+IVT) Ambion MessageAmp kit
Submission date
Sep 28, 2004
Last update date
May 27, 2005
Contact name
Agnes Viale
E-mail(s)
[email protected]
Phone
212 639 3031
Fax
212 717 3053
Organization name
Memorial Sloan Kettering Cancer Center
Department
Molecular Biology
Lab
Genomics Core Laboratory
Street address
1275 York Avenue
City
New York
State/province
NY
ZIP/Postal code
10021
Country
USA
Platform ID
GPL96
Series (1)
GSE1802
CBCD34-TGFbeta targets
Data table header descriptions
ID_REF
VALUE
signal intensity
ABS_CALL
absolute detection call where P=present, A=absent, and M=marginal
DETECTION P-VALUE
confidence on call
Data table
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
AFFX-BioB-5_at
270.7
P
0.000195
AFFX-BioB-M_at
533.5
P
0.00006
AFFX-BioB-3_at
357.1
P
0.000052
AFFX-BioC-5_at
633
P
0.000052
AFFX-BioC-3_at
500.7
P
0.000052
AFFX-BioDn-5_at
719.6
P
0.000044
AFFX-BioDn-3_at
2887.2
P
0.000044
AFFX-CreX-5_at
6129
P
0.000044
AFFX-CreX-3_at
8451.8
P
0.000044
AFFX-DapX-5_at
4.6
A
0.382599
AFFX-DapX-M_at
6.5
A
0.455413
AFFX-DapX-3_at
0.7
A
0.995983
AFFX-LysX-5_at
0.6
A
0.916408
AFFX-LysX-M_at
1.8
A
0.749204
AFFX-LysX-3_at
1.7
A
0.686277
AFFX-PheX-5_at
0.8
A
0.990663
AFFX-PheX-M_at
2.6
A
0.737173
AFFX-PheX-3_at
20.6
A
0.095667
AFFX-ThrX-5_at
6.2
A
0.455413
AFFX-ThrX-M_at
8.7
A
0.559354
Total number of rows:
22283
Table truncated, full table size
578 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|